sellWeak
Pharis Mohideen sold $1,269 of DBVT
Chief Medical Officer at DBV Technologies S.A.. 2,350 shares at an average of $0.54, traded Nov 21, 2024, filed Nov 25, 2024.
Warning score
15Value
$1,269
2,350 shares
Holdings after
112,017
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$1k at market
- 0Share of holdings soldSold 2.1% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-027648, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | AGrant or award Ordinary Shares | +35,000 | $0.00 | $0 | 114,367 | Nov 25, 2024 |
| Nov 21, 2024 | SOpen-market sale Ordinary Shares | -2,350 | $0.54 | $1,269 | 112,017 | Nov 25, 2024 |
| Nov 21, 2024 | AGrant or award Employee Stock Option (right to buy)derivative | +215,000 | $0.00 | $0 | 215,000 | Nov 25, 2024 |
Related signals
Other insiders at DBV Technologies S.A. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 15Weak | sell | DBVT DBV Technologies S.A. | Pharis Mohideen Chief Medical Officer | $510 | 600 | |
| 15Weak | sell | DBVT DBV Technologies S.A. | Pharis Mohideen Chief Medical Officer | $503 | 907 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.